Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients have?
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients has 1,664 citations in the OpenAlex counts ScholarIQ stores.
When was Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients published?
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients has 2020 year in the ScholarIQ index.
What is the open-access status of Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients?
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients has closed oa status in the ScholarIQ index.
What is the DOI of Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients?
The DOI for Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients is on the source record.
What is the PMID of Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients?
The PMID for Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients is on the source record.
What is the OpenAlex record for Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients?
The OpenAlex for Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients is on the source record.